Antimitotic Agents: all 5,052 studies that test it
Page 43 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung CancerCompletedNCT00222144Phase 2
- Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung CancerCompletedNCT00219297Phase 2
- A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerStatus unknownNCT00218205Phase 2
- Preliminary Study of Mycograb and Docetaxel in Advanced Breast CancerCompletedNCT00217815Phase 1/2
- Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
- Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity CancerCompletedNCT00217568Phase 2
- Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00217529Phase 1/2
- Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNCT00216138Phase 2
- Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian CancerCompletedNCT00216112Phase 2
- Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.TerminatedNCT00216008Phase 2
- Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerCompletedNCT00215709Phase 1
- Vinorelbine in Unresectable or Metastatic Esophageal and Gastric AdenocarcinomaCompletedNCT00215462Phase 2
- A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerStatus unknownNCT00215345Phase 2
- Vinblastine and Methotrexate in Children With Pulmonary Vein StenosisCompletedNCT00215046Phase 2
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast CancerCompletedNCT00214864Phase 2
- Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal CancerCompletedNCT00214058Phase 2
- Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade GliomaCompletedNCT00213278Phase 2
- Docetaxel Combined With Ketoconazole in Treatment of Breast CancerCompletedNCT00212095Phase 2
- Gene Expression Profiles in Predicting Chemotherapy Response in Breast CancerCompletedNCT00212082Phase 2
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2
- Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.SuspendedNCT00209729Phase 1/2
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.CompletedNCT00209716Phase 1/2
- Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.CompletedNCT00209690Phase 1/2
- Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.WithdrawnNCT00209612Phase 1/2
- Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric AdenocarcinomaTerminatedNCT00209079Phase 2
- Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of EsophagusTerminatedNCT00208936Phase 2
- Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced MalignanciesCompletedNCT00207129Phase 1
- A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced MalignanciesTerminatedNCT00207025Phase 1
- Neoadjuvant TaxotereCompletedNCT00206505Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast CancerTerminatedNCT00206453Phase 2
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00201812Phase 1
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple MyelomaCompletedNCT00201695Phase 2
- Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in AdultsCompletedNCT00199082Phase 4
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedNCT00198991Phase 4
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00198978Phase 4
- Chemoradiotherapy of NSCLC Stage IIIBCompletedNCT00198432Phase 2
- Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
- Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast CancerCompletedNCT00198237Phase 2
- Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.TerminatedNCT00195325Phase 1
- Study Evaluating TTI-237 in Advanced Malignant Solid TumorsTerminatedNCT00195247Phase 1
- Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerCompletedNCT00194740Phase 2
- Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast CancerCompletedNCT00194727Phase 2
- Chemoradiotherapy in Patients With Localised Lung CancerCompletedNCT00193921Phase 2
- Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid TumorsCompletedNCT00193570Phase 1
- Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine CarcinomaCompletedNCT00193531Phase 2
- Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerCompletedNCT00193362Phase 3
- Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsCompletedNCT00193323Phase 2
- Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal CarcinomaCompletedNCT00193297Phase 2
- Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate CancerCompletedNCT00193271Phase 2
- Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung CancerCompletedNCT00193245Phase 2
- Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate CancerCompletedNCT00193232Phase 2
- Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate CarcinomaCompletedNCT00193193Phase 2
- Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal CancerCompletedNCT00193141Phase 2
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast CancerCompletedNCT00193089Phase 2
- Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast CancerTerminatedNCT00193024Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast CancerCompletedNCT00192062Phase 2
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2
- A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung CancerCompletedNCT00191490Phase 2
- Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic AgentsCompletedNCT00191438Phase 3
- Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung CancerCompletedNCT00191256Phase 2
- Docetaxel vs. Docetaxel-Gemcitabine in Breast CancerCompletedNCT00191243Phase 2
- A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast CancerCompletedNCT00190489Phase 3
- Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early RelapseCompletedNCT00189566Phase 2
- Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or PeritoneumTerminatedNCT00189371Phase 3
- Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHLCompletedNCT00187161Phase 2
- Treatment for Patients With Stage III or IV Non-Hodgkin LymphomaCompletedNCT00187122Not applicable
- A Study of Children With Refractory or Relapsed ALLCompletedNCT00187083Phase 3
- Large Cell Lymphoma Pilot Study IIICompletedNCT00187070Not applicable
- Study for Treatment of Cancer in Children With Ataxia-telangiectasiaCompletedNCT00187057Not applicable
- Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00187005Phase 3
- Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and RadiationCompletedNCT00186420Phase 2
- Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder CancerCompletedNCT00186277Phase 2
- Intensified Post Remission Therapy Containing PEG-AsparaginaseCompletedNCT00184041Phase 2
- Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to ChemotherapyTerminatedNCT00183950Phase 1/2
- Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.CompletedNCT00183924Phase 2
- Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)CompletedNCT00183742Phase 1
- Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney CancerCompletedNCT00182702Phase 2
- Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian OriginCompletedNCT00181701Phase 2
- Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine CervixCompletedNCT00178269Phase 2
- Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00176527Phase 2
- Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck CancerCompletedNCT00176267Phase 2
- Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerTerminatedNCT00176241Phase 1
- Study Of SU011248 In Combination With Paclitaxel In Patients With Metastatic Breast CancerCompletedNCT00174434Phase 1
- PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC PatientsCompletedNCT00174356Phase 1
- Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00173888Phase 2
- Phase II Study of Docetaxel Plus CDDP for NSCLC Stage IIICompletedNCT00172380Phase 2
- SB-715992 In Combination With Docetaxel In Patients With Solid TumorsCompletedNCT00169520Phase 1
- Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx CarcinomaCompletedNCT00169182Phase 3
- Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat CancersCompletedNCT00169000Phase 1
- Study for Patients With Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00168883Phase 2
- Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung CancerCompletedNCT00167401Phase 2
- A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid TumorsCompletedNCT00165802Phase 1
- Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerCompletedNCT00165464Phase 2
- Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local TreatmentCompletedNCT00165399Phase 2
- Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
- Efficacy and Treatment Related Toxicity Study of a New Regimen for LymphomaCompletedNCT00163748Phase 2